Abstract
Microcrystalline cellulose is an excipient widely used in solid dosage forms as adsorbent, suspending agent, diluent, and disintegrant, depending on the percentage employed in the formulation. The structural similarity between cellulose and chitosan and the ecological advantage in the manufacturing process of chitosan have justified and reinforced the study of this polysaccharide as a novel pharmaceutical excipient. Nevertheless, it still does not appear to be present as constituent in any marketed medicine due to the absence of regulatory hurdles to standardize its physicochemical and functional specifications as well as its compatibility with other formulation ingredients. The physical compatibilities between chitosan and the most excipients used in solid dosage forms, such as diluents (microcrystalline cellulose, starch, lactose monohydrate, dicalcium phosphate dihydrate, and calcium carbonate), disintegrants (sodium starch glycolate, and croscarmellose sodium), and glidants (magnesium stearate, talc, sodium lauryl sulfate, and colloidal silicon dioxide), were studied by thermal analysis and FT-IR. In order to facilitate the IR spectra interpretations, an ad hoc algorithm was used to generate theoretical spectra to be compared with the respective experimental ones. Chitosan proved to be physically compatible with microcrystalline cellulose, starch, lactose, sodium starch glycolate, croscarmellose sodium, talc, colloidal silicon dioxide, and sodium lauryl sulfate. Moreover, chitosan raises the thermal stability of cellulose from 310 to 330 °C. Once the amino groups of chitosan were able to form coordination complexes with divalent cations of dicalcium phosphate dihydrate, calcium carbonate, and magnesium stearate, they were considered incompatible with chitosan.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have